China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Want to see HK:1011 full AI Analyst Report?
Total Valuation
China NT Pharma Group Co., Ltd. has a market cap or net worth of HK$578.89M. The enterprise value is HK$657.45M.
Market CapHK$578.89M
Enterprise ValueHK$657.45M
Share Statistics
China NT Pharma Group Co., Ltd. has 948,997,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding948,997,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China NT Pharma Group Co., Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -28.83%.
Return on Equity (ROE)0.10
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-28.83%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee1.10M
Profits Per Employee-1.15M
Employee Count22
Asset Turnover0.07
Inventory Turnover36.26
Valuation Ratios
The current PE Ratio of China NT Pharma Group Co., Ltd. is ―. China NT Pharma Group Co., Ltd.’s PEG ratio is 0.22.
PE Ratio―
PS Ratio18.81
PB Ratio-1.66
Price to Fair Value-1.66
Price to FCF-18.39
Price to Operating Cash Flow-14.56
PEG Ratio0.22
Income Statement
In the last 12 months, China NT Pharma Group Co., Ltd. had revenue of 24.16M and earned -26.04M in profits. Earnings per share was -0.04.
Revenue24.16M
Gross Profit9.61M
Operating Income-12.36M
Pretax Income-26.25M
Net Income-26.04M
EBITDA-12.32M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -24.55M and capital expenditures -154.88K, giving a free cash flow of -24.71M billion.
Operating Cash Flow-24.55M
Free Cash Flow-24.71M
Free Cash Flow per Share-0.03
Dividends & Yields
China NT Pharma Group Co., Ltd. pays an annual dividend of HK$0.035, resulting in a dividend yield of ―
Dividend Per ShareHK$0.035
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change38.64%
50-Day Moving Average0.68
200-Day Moving Average0.81
Relative Strength Index (RSI)41.68
Average Volume (3m)1.68M
Important Dates
China NT Pharma Group Co., Ltd. upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
China NT Pharma Group Co., Ltd. as a current ratio of 0.02, with Debt / Equity ratio of -115.74%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.70
Net Debt to EBITDA-25.14
Interest Coverage Ratio-0.46
Taxes
In the past 12 months, China NT Pharma Group Co., Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China NT Pharma Group Co., Ltd. EV to EBITDA ratio is -62.03, with an EV/FCF ratio of -30.92.
EV to Sales31.63
EV to EBITDA-62.03
EV to Free Cash Flow-30.92
EV to Operating Cash Flow-31.12
Balance Sheet
China NT Pharma Group Co., Ltd. has HK$7.22M in cash and marketable securities with HK$316.83M in debt, giving a net cash position of -HK$309.61M billion.
Cash & Marketable SecuritiesHK$7.22M
Total DebtHK$316.83M
Net Cash-HK$309.61M
Net Cash Per Share-HK$0.33
Tangible Book Value Per Share-HK$0.44
Margins
Gross margin is 39.78%, with operating margin of -51.18%, and net profit margin of -107.79%.
Gross Margin39.78%
Operating Margin-51.18%
Pretax Margin-108.68%
Net Profit Margin-107.79%
EBITDA Margin-50.98%
EBIT Margin-51.18%
Analyst Forecast
The average price target for China NT Pharma Group Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-36.32%
EPS Growth Forecast78.17%